Applied Manufacturing Technologies Achieves Multiple FANUC Awards for Outstanding Sales

Applied Manufacturing Technologies (AMT), North America’s largest independent automation engineering company supporting manufacturers, robot companies, systems integrators, line builders and users of robotic automation worldwide, has announced that the company has received FANUC America Corporation’s Sales Growth Award for the fourth time and was also presented with the Sales Leadership Award for FANUC Authorized System Integrators.

AMT is not a stranger to receiving FANUC’s Sales Growth Award, having been recognized in 2015, 2018, and 2021. The award is announced annually the at FANUC Authorized System Integrator (ASI) conference, which was held in February of this year in Carlsbad, California.

In addition to the Sales Growth Award, Applied Manufacturing Technologies has achieved another rare award for integrators: the FANUC Leadership Award. This award is given to integrators who have reached the milestone of selling more than 50 robots in one year.

“We at AMT are honored to receive the Sales Leadership Award and to once again be recognized by FANUC with a premier Sales Growth Award and celebrating AMT’s strongest growth year in history,” said Craig Salvalaggio, chief operating officer at AMT. “We share a similar culture with FANUC and are proud of our strong, decades-long partnership with FANUC and will continue to deliver best-in-class manufacturing solutions to clients with them as a strategic partner.”

During the award ceremony reception Fanuc’s Vice President Lou Finazzo spoke to AMT’s staff and praised the company for being an elite and reliable systems integrator and developing some of the best talent to support the industry.

A FANUC Level V System Integrator and four-time winner of the FANUC Sales Growth Award, Applied Manufacturing Technologies offers full-service systems integration, specializing in end-of-line solutions, complex material handling systems, and engineering support such as turnkey industrial controls, robotic programming, and automation consulting. Bringing together best-in-class technologies and custom automation, AMT provides high-quality, cost-effective automation solutions. The company’s solutions have benefited manufacturers in automotive, aerospace, medical, alternative energy, fabricated metal, industrial machinery, rubber and plastics, food and beverage, and many other industries.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”